Jhonatan R Mejia
Dados Biográficos
| ID | 7985231 |
|---|---|
| NOME | Jhonatan R Mejia |
| PRENOMES | Jhonatan R |
| SOBRENOME | Mejia |
| ASSINATURA | MEJIA J R |
| AFILIAÇÕES | Instituto de Efectividad Clínica y Sanitaria |
| ORCID | 0000-0002-9846-8503 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 2 |
| TOTAL DE CITAÇÕES | 0 |
| OBRAS COMO AUTOR | 2 |
| OBRAS COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2023 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2025 |
| ÍNDICE H | 0 |
Disease burden from tobacco consumption in Peru and the projected effect of strengthening control measures
Motivation for the study. Despite progress in tobacco control, the economic and disease burden in Peru remains high. Strengthening smoke-free regulations, implementing plain packaging, banning tobacco promotion and sponsorship, and increasing taxes could reduce it. Main findings. Tobacco use causes 22,350 deaths and 126,000 disease events annually in Peru, resulting in a loss of 1.28% of GDP. Strengthening tobacco control policies would prevent t…
Uso de medicamentos en pacientes pediátricos con Covid-19 hospitalizados en un hospital de referencia de Lima, Perú
Motivation for the study. Therapeutic guidelines for COVID-19 in children changed constantly during the pandemic. In Peru, the variation of the treatment during the different waves of the pandemic has not been studied. Main findings. During the third wave, there was a greater number of patients with COVID-19; however, these patients had less severe symptoms. The use of ceftriaxone and azithromycin was less frequent during the third wave. The use …
Sem obras proeminentes nesta página.
Uso de medicamentos en pacientes pediátricos con Covid-19 hospitalizados en un hospital de referencia de Lima, Perú
Motivation for the study. Therapeutic guidelines for COVID-19 in children changed constantly during the pandemic. In Peru, the variation of the treatment during the different waves of the pandemic has not been studied. Main findings. During the third wave, there was a greater number of patients with COVID-19; however, these patients had less severe symptoms. The use of ceftriaxone and azithromycin was less frequent during the third wave. The use …
Disease burden from tobacco consumption in Peru and the projected effect of strengthening control measures
Motivation for the study. Despite progress in tobacco control, the economic and disease burden in Peru remains high. Strengthening smoke-free regulations, implementing plain packaging, banning tobacco promotion and sponsorship, and increasing taxes could reduce it. Main findings. Tobacco use causes 22,350 deaths and 126,000 disease events annually in Peru, resulting in a loss of 1.28% of GDP. Strengthening tobacco control policies would prevent t…
Medicine (2 obras) · Population (2 obras) · 2019-20 coronavirus outbreak (1 obra) · Consumption (sociology (1 obra) · Coronavirus disease 2019 (COVID-19 (1 obra) · COVID-19 Clinical Research Studies (1 obra) · Disease (1 obra) · Disease burden (1 obra) · Economics (1 obra) · Enforcement (1 obra)